Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry May 2020 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia Sep 2024 Annals of Hematology Aplastic Anemia
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes Oct 2020 Annals of internal medicine Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nov 2020 Annals of Oncology: Official Journal of the European Society for Medical Oncology Myelodysplastic Syndromes (MDS)
A Journey from Blood Cells to Genes and Back Aug 2023 Annual Review of Genomics and Human Genetics Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy Oct 2023 Annual Review of Pathology: Mechanisms of Disease Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? May 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS)
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)